Introduction {#ss1}
============

Laboratory expenses have increased considerably in recent years ([@CIT0001]). The growing prominence of laboratory science in diagnostic practices ([@CIT0002]) and information technology advances that enhance test accessibility ([@CIT0003]) increases test use. However, the same factors also predispose to over-use and misuse.

The proportion of inappropriate test requests ranges from 4.5% to 95%, in studies of medical records ([@CIT0004]) using implicit and explicit criteria. These studies are complex, difficult to conduct, and generally not cost-effective, because tests are usually a relatively low-cost item. Studies to compare ordering behavior are a less expensive way to obtain information useful for optimizing laboratory test use.

Demand for laboratory testing services by primary care in eight Health Care Departments of the Valencia Health Agency in 2009 was evaluated in this study using a range of pathology tests representing 90% of requests in general practice to compare primary care test ordering behavior.

Material and methods {#ss2}
====================

The study was carried out under the auspices of the Valencia Health Agency to compare 2009 tests requested by general practitioners (GPs). The network was created by issuing two surveys to 13 laboratories (March 2008). The inclusion criteria were a common laboratory information system (LIS) (Omega, Roche Diagnostic^®^, Spain) and a data warehouse application capable of stratifying LIS results among clients (in-patients, primary care patients, etc.). The eight laboratories included provide services to hospitalized, emergency, specialized, and primary care patients whose samples are obtained in primary health care centers for hematology and blood chemistry tests. The population served in each Health Care Department is shown in [Table I](#T1){ref-type="table"}. In stage 2, we defined and validated the registers and indicators and created a common database. In stage 3 (March 2010), the results were presented confidentially to participating hospitals at a meeting. Each laboratory representative knew only the identification of their own data. A 2-month period of reflection and suggestions followed.

###### 

Tests/1,000 inhabitants in 2009 in different health care areas. These areas received health services from different Health Care Departments to which the different laboratories participating in the study pertain.

                                  Health care areas (total population December 2009)                                       
  ------------------------------- ---------------------------------------------------- ----- ----- ----- ----- ----- ----- -----
  General                                                                                                                  
   Alanine aminotransferase       383                                                  364   350   293   380   209   298   280
   Alkaline phosphatase           85                                                   149   54    117   73    75    113   98
   Aspartate aminotransferase     169                                                  224   140   107   95    202   298   280
   Cholesterol                    318                                                  363   337   339   422   215   351   276
   Creatinine                     511                                                  364   345   324   387   219   311   276
   Gamma-glutamyltranspeptidase   156                                                  341   314   106   376   193   249   267
   Glucose                        524                                                  373   356   350   408   239   368   278
   HDL cholesterol                228                                                  239   200   250   306   199   329   207
   Potassium                      341                                                  167   157   309   203   97    165   135
   Total bilirubin                154                                                  139   100   94    143   95    103   56
   Triglycerides                  317                                                  361   333   338   423   199   348   275
   Urea                           381                                                  112   91    145   117   212   285   56
   Uric acid                      313                                                  340   329   173   363   183   293   265
  Anemia profile                                                                                                           
   Iron                           102                                                  207   86    89    100   52    185   73
   Ferritin                       92                                                   146   87    87    118   45    121   110
   Transferrin                    38                                                   15    59    12    78    10    34    19
  Rheumatic profile                                                                                                        
   C-reactive protein             167                                                  147   54    58    115   110   71    75
   Calcium                        156                                                  43    284   100   129   44    68    37
   Phosphate                      85                                                   37    253   95    86    30    40    32
   Rheumatoid factor              24                                                   33    57    64    31    26    44    42
  Thyroid profile                                                                                                          
   Free thyroxine                 95                                                   110   42    18    68    117   74    42
   Thyrotropin                    152                                                  140   160   82    226   117   147   100

The daily LIS registers (tests requested by GPs) were collected and indicators were calculated using a computer application based on data warehouse and OnLine Analytical Processing OLAP cubes (Omnium, Roche Diagnostic^®^, Spain). Every test request per 1,000 inhabitants (22 chemistry tests) and the appropriate indicators that measured the number of tests per related test requested (aspartate aminotransferase/alanne aminotransferase, urea/creatinine, free thyroxine/thyrotropin) by GPs were calculated.

The savings generated, if each Health Care Department achieved the appropriate indicator standard (0.2 for aspartate aminotransferase/alanine aminotransferase, 0.1 for urea/creatinine, and 0.25 for thyroxine/thyrotropin), were also calculated ([@CIT0005]).

Results {#ss3}
=======

[Table I](#T1){ref-type="table"} shows the test requests per 1,000 inhabitants per Health Care Department in 2009 grouped according to the tests most used in primary care. There was a large difference in demand for tests by health areas.

The appropriate indicators (ratio of related tests) are shown in [Table II](#T2){ref-type="table"}. The ratio of related tests also showed a great variability.

###### 

Value of the appropriate indicators that measure the number of tests per related tests requested by General Practitioners in different Health Care Departments.

                                                            Health care areas                                                   
  --------------------------------------------------------- ------------------- ------- ------- ------- ------- ------- ------- -------
  Key Performance Indicator (KPI)                                                                                               
   Aspartate amino transferase/ Alanine amino transferase   0.435               0.611   0.404   0.372   0.246   0.962   1.000   1.000
   Urea / Creatinine                                        0.725               0.285   0.283   0.455   0.298   0.968   0.918   0.198
   Free thyroxine / Thyrotropin                             0.587               0.701   0.269   0.255   0.306   1.000   0.504   0.419

The savings generated, if each Health Care Department had achieved the appropriate indicator standard, were €253,083: €18,289 for aspartate aminotransferase, €62,678 for urea, and €172,116 for thyroxine.

Discussion {#ss4}
==========

Studies to evaluate clinical laboratory activities are a tool increasingly used to compare performance between organizations using the same measures and the same measurement system. It took 2 years to set up the laboratory network and data collection process and to identify suitable indicators for comparing primary care requesting performance.

Primary care demand for tests is growing ([@CIT0006]) in terms of requests per inhabitant or per doctor. Our results demonstrate the broad variability of demand for tests by primary care on a test-by-test basis. It is not easy to establish a relationship between variability and center characteristics. All departments participating in the study, except one, are in an urban and coastal zone and are also influenced by seasonal tourism. The Valencian Community ranks the fourth most populated autonomous community of Spain, in a very populated country. There is no significant difference between the percentages of population aged \>65 years in different centers. Five hospitals are university hospitals, but it is not possible to establish a relationship between the indicator values and the type of hospital.

It is strange to observe the great differences in serum glucose requesting, and the duplicated demand for potassium and sodium (the sodium results were not reported because they were identical to the potassium in all Health Care Departments) from one health area to another, where the prevalence of hypertension and need for monitoring are probably similar. Probably, different uses of lipids and uric acid measurements in the prevention of hypercholesterolemia and metabolic syndrome, respectively, will be responsible for large differences in requests ([@CIT0007]). Moreover, uric acid is requested out of habit. In addition, despite evidence to the contrary, most GPs believe that an annual physical examination detects subclinical illness ([@CIT0008]). Many report using laboratory tests for screening purposes with little evidence to support the practice, although it has become less frequent ([@CIT0009]) as evidence-based guidelines have come into use and medical cost containment has become a concern.

Larsson et al. ([@CIT0005]) recommend using serum alanine aminotransferase and alkaline phosphatase as the only liver markers and demonstrated the enormous savings that would result from reducing demand for aspartate aminotransferase, bilirubin, and gamma-glutamyltranspeptidase, which varied widely in the study.

Laboratory tests to diagnose anemia are subject to both under-use and over-use ([@CIT0010]). It is well known that iron alone should not be ordered as part of an anemia investigation. However, it is surprising that certain departments are requesting from 3 to 10 times more iron than transferrin tests. Despite the iron test being cheap, its uselessness as an isolated test and the high within-person biological variation of serum iron indicate that early establishment of corrective measures is required to reduce its isolated request and to highlight the need for iron and transferrin to be used in combination. It is an archaic habit, important to change soon.

The variability in requests for rheumatic and thyroid disease tests is also noteworthy; for instance, free thyroxin is requested despite evidence that it may be generated after abnormal thyrotropin in primary care patients. There is also a huge difference in the requesting patterns of calcium, possibly an 'under-used' test in some areas. Treatable primary hyperparathyroidism disease in patients who are generally free of somatic manifestations is most often diagnosed when routine biochemical testing shows an elevated serum calcium level. The advent of automated laboratory serum analyzers in the 1960s allowed for the detection of 'asymptomatic hypercalcemia', and the incidence of hyperparathyroidism increased 5-fold during the next two decades. However, nowadays hyperparthyroidism can be again overlooked due to the disappearance of analyzers of continuous type. Calcium is a parameter whose use should be encouraged.

Probably, high demand for C-reactive protein tests in area A indicated more frequent use to detect/monitor infectious/rheumatoid diseases, when compared to other areas.

In certain health areas, urea and creatinine requests were similar, and transferase requests were identical (1:1 demand ratio). However, there is evidence indicating that serum urea provides little more information than serum creatinine alone ([@CIT0011]), as also applies to the two transferases. We only studied the economic effects of decreasing three serum chemistry test ratios, and the total savings would be great. If we use these figures to calculate the total savings for all health care areas in Valencian Community, and more tests ratios, it would represent an enormous saving.

The great differences observed in the study in all test requests in such a large population are inconsistent with the goal of providing equitable care and apparently reflect local traditions ([@CIT0005]). The differences are probably due to individual variations in clinical practice; however, they still undermine laboratory cost-effectiveness efforts and could be changed ([@CIT0012]), preferably through regional strategies developed by consensus between GPs and clinical pathologists and formalized in health care governance measures.

Given the large difference in requesting patterns between health areas, the first step in optimizing laboratory test use would be to establish basic reflex testing strategies. Implementation of these measures would then be monitored using appropriate indicators, which actually vary greatly from one district to another, after setting clear goals. Nowadays most tests are added by automated analysers in accordance with algorithms. Previous process mapping will be needed in less automated laboratories. Laboratory directors should be aware that any strategy implemented to reduce inappropriate test use will reduce the number of tests processed by personnel and will appear to diminish theoretical performance. However, higher-quality diagnostic information would be obtained. In addition, unexpected results and false positives would decrease, and, concomitantly, so would the number of diagnostic tests performed and specialist consultations required for their interpretation, which are an important source of anxiety for patients. This is where the contribution of laboratory professionals is critical, by providing fewer, more selective, optimally effective diagnostic data.

Laboratory data are involved in 70% of clinical decisions ([@CIT0013]); however, laboratory costs usually account for a very small proportion of overall health care costs. Patients should receive the full benefit from laboratory medicine, and it is important to encourage the use of some tests, such as serum calcium.

This study revealed that considerable variability exists in the use of laboratory tests by eight health areas. It also identified appropriate indicators that can be applied across a spectrum of clinical laboratories, and which thus may be useful for examining requesting patterns. The study highlighted the need to unify demand by optimizing the use of appropriate tests through interdepartmental communication and rigorous application of scientific evidence ([@CIT0014]).
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